Tri-lo-mili Kit
Product Images NDC 65862-778

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tri-lo-mili (NDC 65862-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Pack Label (Norgestimate Fig1)

Tri-Lo-Mili kit packaging label showing a 4-week pill schedule with 28 circular tablets arranged in rows by day of week (Sun to Sat). The color-coded rows represent different tablet strengths and formulations: white to off-white, pale blue to bluish white, blue to light blue, and green tablets. The label includes the active ingredients norgestimate and ethinyl estradiol with respective dosages.*

FDA Label Image

Day Label Sticker (Norgestimate Fig2)

An instructional illustration showing use of Tri-Lo-Mili oral contraceptive kit labels. It depicts a hand positioning a day-of-week label strip above the blister pack containing four color-coded rows of tablets (white to off-white, pale blue to bluish white, blue to light blue, and green), each row labeled by week and dosage strengths of norgestimate and ethinyl estradiol tablets. Instructions indicate to pick the correct day label and place it over the designated area on the blister pack.*

FDA Label Image

Pregnancy Chart (Norgestimate Fig3)

A forest plot chart showing effect estimates with 95% confidence intervals from various studies including NICHD Women's Contraceptive Study, French F3N cohort Study, Shangai Womens Health Study, The Nurses' Health Study, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis represents effect estimates (odds ratios or relative risks) ranging from -1.5 to 2, with most estimates around or above 1.*

FDA Label Image

Blister Pack Label1 (Norgestimate Fig4)

An infographic illustrating pregnancy rates per 100 women in one year categorized by different birth control methods. It ranks methods from fewer than 1 pregnancy per 100 women annually (implants, injections, intrauterine devices, sterilization) to 85 or more pregnancies per 100 women annually with no birth control. Intermediate categories include birth control pills, skin patch, vaginal ring, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

Day Label Sticker1 (Norgestimate Fig5)

An instructional diagram illustrating the weekly tablet schedule for Tri-Lo-Mili tablets containing norgestimate and ethinyl estradiol. It shows a grid layout of days Sunday to Saturday across four weeks, with color-coded circles representing tablet colors and dosages: white to off-white for week 1, pale blue to bluish white for week 2, blue to light blue for week 3, and green for week 4. Arrows indicate the sequence starting from week 1 to week 4.*

FDA Label Image

Package Label-principal Display Panel (Blister Pouch Label)

An instructional diagram for the Tri-Lo-Mili kit showing how to use the day-of-week label with the blister pack. The blister pack contains four rows of tablets in different shades from white to green, corresponding to weeks 1 through 4. A hand is shown peeling a strip of day labels (MON to SUN) to place above the tablets to track daily dosing.*

FDA Label Image

Package Label-principal Display Panel (Pouch Carton)

Tri-Lo-Mili kit packaging label for a 28-day regimen containing norgestimate and ethinyl estradiol tablets USP in strengths of 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label indicates it contains 1 pouch of 28 tablets and is distributed by Aurobindo Pharma Limited. The label includes a note that the product is intended to prevent pregnancy but does not protect against HIV or other sexually transmitted diseases, and is Rx only.*

FDA Label Image

Norgestimate Fig8

Tri-Lo-Mili kit packaging label displaying tablets of norgestimate and ethinyl estradiol in strengths of 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. The label states a 28-day regimen, contains 6 pouches each with 28 tablets, and is labeled by Aurobindo Pharma Limited. The box also includes warning and storage information, and a barcode on the bottom panel.*

FDA Label Image

Norgestimate Fig9

Packaging label for Tri-Lo-Mili kit containing norgestimate and ethinyl estradiol tablets USP. The label lists strengths as 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. It indicates a 28-day regimen with 6 cartons each containing 28 tablets. The labeler is Aurobindo Pharma Limited with distribution by Aurobindo Pharma USA, Inc.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagram showing the molecular structures of Norgestimate and Ethinyl Estradiol, the active ingredients in Tri-Lo-Mili. Each structure is labeled accordingly with distinct chemical bond representations and atom groupings typical of steroid hormones.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.